Stock-Based Compensation

9 Months Ended

Sep. 30, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

The Company classifies stock-based compensation expense in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss, based on the department to which the recipient belongs. Stock-based compensation expense included in cost of goods sold and operating expenses during the three and nine months ended September 30, 2015 and 2014, was as follows:



	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2015		2014			2015		2014
Cost of goods sold	$	257	$	240		$	731	$	643
Operating expenses:
Research and development	252		207			737		543
Clinical and regulatory affairs	321		(195		)	749		67
Marketing and sales	888		931			2,476		2,125
General and administrative	832		632			2,476		2,190
Total operating expenses	$	2,293	$	1,575		$	6,438	$	4,925
Total	$	2,550	$	1,815		$	7,169	$	5,568